Table 7.
Comparison of Short-Form-36 score between experimental and control groups at the end of 15 days and 30 days of treatment regimen
| Variables | Mean difference (SD) | P | |
|---|---|---|---|
| Experimental group | Control group | ||
| SF36_D_1_15 days | 2.81 (1.54) | 1.85 (0.97) | <0.001* |
| SF36_D_2_15 days | 8.11 (4.68) | 3.3 (1.71) | <0.001* |
| SF36_D_3_15 days | 3.11 (0.87) | 1.22 (0.83) | <0.001* |
| SF36_D_4_15 days | 2.72 (1.00) | 0.77 (0.57) | <0.001* |
| SF36_D_5_15 days | 3.16 (1.34) | 1.25 (0.77) | <0.001* |
| SF36_D_6_15 days | 9.53 (4.40) | 4.52 (4.80) | <0.001* |
| SF36_D_7_15 days | 1.34 (.68) | 0.95 (0.74) | 0.013* |
| SF36_D_8_15 days | 2.46 (1.20) | 1.52 (0.87) | <0.001* |
| SF36_D_1_30 days | 5.25 (1.54) | 3.95 (1.41) | 0.0001* |
| SF36_D_2_30 days | 12.18 (3.84) | 9.22 (2.86) | 0.0002* |
| SF36_D_3_30 days | 3.74 (0.44) | 2.87 (0.93) | <0.001* |
| SF36_D_4_30 days | 3.81 (0.73) | 2.47 (1.03) | <0.001* |
| SF36_D_5_30 days | 6.09 (1.25) | 2.42 (1.51) | <0.001* |
| SF36_D_6_30 days | 16.83 (5.14) | 11.17 (5.72) | <0.001* |
| SF36_D_7_30 days | 2.48 (0.82) | 0.97 (1.36) | <0.001* |
| SF36_D_8_30 days | 5.18 (1.41) | 3.97 (1.59) | 0.0004* |
*P<0.05. SF-36_D_1 to SF-36_D_8=SF-36 domain 1 to SF-36 domain 8. SF=Short Form, SD=Standard deviation